# Hanover Bancorp, Inc.: financial statements, quarterly

HNVR · Nasdaq · CIK 1828588 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/hnvr.md) · [Financials](/companies/hnvr/financials.md) · [Filings](/companies/hnvr/filings.md) · [Insiders](/companies/hnvr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/hnvr/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q4 FY2024 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [17.2 d](/filings/0001558370-23-019964.md) | [18.5](/filings/0001558370-24-001054.md) | [19.5](/filings/0001558370-24-008127.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [1.2](/filings/0001558370-24-015516.md) | [1.3](/filings/0001558370-25-003018.md) | [1.3](/filings/0001558370-25-007164.md) | [0.3](/filings/0001558370-25-010918.md) | [1.1](/filings/0001104659-25-108453.md) | [1.3 d](/filings/0001104659-26-027651.md) | [0.2](/filings/0001104659-26-057877.md) | [0.9](/filings/0001104659-26-092675.md) | [1.2](/filings/0001104659-25-108453.md) | [0.1 d](/filings/0001104659-26-027651.md) | [1.1](/filings/0001104659-26-057877.md) | [1.4](/filings/0001104659-26-092675.md) |
| Net income | $m | [3.5](/filings/0001558370-24-015516.md) | [3.8](/filings/0001558370-25-003018.md) | [4.1](/filings/0001104659-25-108453.md) | [0.8](/filings/0001104659-25-108453.md) | [3.5](/filings/0001104659-25-108453.md) | [3.9 d](/filings/0001104659-26-027651.md) | [1.5](/filings/0001104659-26-092675.md) | [2.4](/filings/0001104659-26-092675.md) | [3.5](/filings/0001104659-25-108453.md) | [0.0 d](/filings/0001104659-26-027651.md) | [1.9](/filings/0001104659-26-092675.md) | [4.1](/filings/0001104659-26-092675.md) |
| Diluted EPS | $ per share | [0.48](/filings/0001558370-24-015516.md) | [0.51](/filings/0001558370-25-003018.md) | [0.55](/filings/0001558370-25-007164.md) | [0.11](/filings/0001558370-25-010918.md) | [0.48](/filings/0001104659-25-108453.md) | not reported | [0.20](/filings/0001104659-26-057877.md) | [0.33](/filings/0001104659-26-092675.md) | [0.47](/filings/0001104659-25-108453.md) | not reported | [0.25](/filings/0001104659-26-057877.md) | [0.55](/filings/0001104659-26-092675.md) |
| Basic EPS | $ per share | [0.48](/filings/0001558370-24-015516.md) | [0.51](/filings/0001558370-25-003018.md) | [0.55](/filings/0001558370-25-007164.md) | [0.11](/filings/0001558370-25-010918.md) | [0.48](/filings/0001104659-25-108453.md) | not reported | [0.20](/filings/0001104659-26-057877.md) | [0.33](/filings/0001104659-26-092675.md) | [0.47](/filings/0001104659-25-108453.md) | not reported | [0.25](/filings/0001104659-26-057877.md) | [0.55](/filings/0001104659-26-092675.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-09-30) | FY2024 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [193](/filings/0001558370-25-003018.md) | [177](/filings/0001558370-25-003018.md) | [136](/filings/0001558370-24-008127.md) | [141](/filings/0001558370-24-012050.md) | [141](/filings/0001558370-24-015516.md) | [163](/filings/0001104659-26-027651.md) | [160](/filings/0001558370-25-007164.md) | [165](/filings/0001558370-25-010918.md) | [168](/filings/0001104659-25-108453.md) | [209](/filings/0001104659-26-092675.md) | [194](/filings/0001104659-26-057877.md) | [141](/filings/0001104659-26-092675.md) |
| Total assets | $m | [2,150](/filings/0001558370-25-003018.md) | [2,270](/filings/0001558370-25-003018.md) | [2,308](/filings/0001558370-24-008127.md) | [2,331](/filings/0001558370-24-012050.md) | [2,328](/filings/0001558370-24-015516.md) | [2,312](/filings/0001104659-26-027651.md) | [2,292](/filings/0001558370-25-007164.md) | [2,312](/filings/0001558370-25-010918.md) | [2,332](/filings/0001104659-25-108453.md) | [2,383](/filings/0001104659-26-092675.md) | [2,371](/filings/0001104659-26-057877.md) | [2,337](/filings/0001104659-26-092675.md) |
| Total liabilities | $m | [1,964](/filings/0001558370-25-003018.md) | [2,085](/filings/0001558370-25-003018.md) | [2,118](/filings/0001558370-24-008127.md) | [2,141](/filings/0001558370-24-012050.md) | [2,135](/filings/0001558370-24-015516.md) | [2,115](/filings/0001104659-26-027651.md) | [2,095](/filings/0001558370-25-007164.md) | [2,113](/filings/0001558370-25-010918.md) | [2,130](/filings/0001104659-25-108453.md) | [2,183](/filings/0001104659-26-092675.md) | [2,170](/filings/0001104659-26-057877.md) | [2,134](/filings/0001104659-26-092675.md) |
| Short-term borrowings | $m | [180](/filings/0001558370-25-003018.md) | [129](/filings/0001558370-25-003018.md) | [149](/filings/0001558370-24-008127.md) | [149](/filings/0001558370-24-012050.md) | [126](/filings/0001558370-24-015516.md) | [108](/filings/0001104659-26-027651.md) | [108](/filings/0001558370-25-007164.md) | [108](/filings/0001558370-25-010918.md) | [101](/filings/0001104659-25-108453.md) | [101](/filings/0001104659-26-092675.md) | [59.8](/filings/0001104659-26-057877.md) | [59.8](/filings/0001104659-26-092675.md) |
| Shareholders' equity | $m | [186](/filings/0001558370-25-003018.md) | [185](/filings/0001104659-26-027651.md) | [190](/filings/0001104659-25-108453.md) | [190](/filings/0001104659-25-108453.md) | [192](/filings/0001104659-25-108453.md) | [197](/filings/0001104659-26-092675.md) | [197](/filings/0001104659-26-092675.md) | [199](/filings/0001104659-26-092675.md) | [202](/filings/0001104659-25-108453.md) | [200](/filings/0001104659-26-092675.md) | [201](/filings/0001104659-26-092675.md) | [203](/filings/0001104659-26-092675.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q4 FY2024 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [0.9 d](/filings/0001558370-25-003018.md) | [4.1](/filings/0001558370-25-003018.md) | [3.6](/filings/0001558370-25-007164.md) | [(3.1) d](/filings/0001558370-25-010918.md) | [(0.5) d](/filings/0001104659-25-108453.md) | [5.5 d](/filings/0001104659-26-027651.md) | [0.3](/filings/0001104659-26-057877.md) | [1.8 d](/filings/0001104659-26-092675.md) | [2.7 d](/filings/0001104659-25-108453.md) | [8.3 d](/filings/0001104659-26-027651.md) | [(2.5)](/filings/0001104659-26-057877.md) | [18.4 d](/filings/0001104659-26-092675.md) |
| Capital expenditure | $m | [0.3 d](/filings/0001558370-25-003018.md) | [0.4](/filings/0001558370-25-003018.md) | [0.3](/filings/0001558370-25-007164.md) | [1.4 d](/filings/0001558370-25-010918.md) | [0.3 d](/filings/0001104659-25-108453.md) | [(0.8) d](/filings/0001104659-26-027651.md) | [0.2](/filings/0001104659-26-057877.md) | [0.1 d](/filings/0001104659-26-092675.md) | [0.3 d](/filings/0001104659-25-108453.md) | [0.2 d](/filings/0001104659-26-027651.md) | [0.2](/filings/0001104659-26-057877.md) | [0.4 d](/filings/0001104659-26-092675.md) |
| Dividends paid | $m | [0.7 d](/filings/0001558370-23-019964.md) | [0.7](/filings/0001558370-25-003018.md) | [0.7](/filings/0001558370-25-007164.md) | [0.7 d](/filings/0001558370-25-010918.md) | [0.7 d](/filings/0001104659-25-108453.md) | [0.7 d](/filings/0001104659-26-027651.md) | [0.7](/filings/0001104659-26-057877.md) | [0.8 d](/filings/0001104659-26-092675.md) | [0.7 d](/filings/0001104659-25-108453.md) | [0.8 d](/filings/0001104659-26-027651.md) | [0.7](/filings/0001104659-26-057877.md) | [0.7 d](/filings/0001104659-26-092675.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [1.3 d](/filings/0001104659-26-027651.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock, us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2023 (2023-03-31) | Q3 FY2023 (2023-06-30) | Q4 FY2023 (2023-09-30) | Q4 FY2024 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [7,103](/filings/0001558370-24-008127.md) | [7,145](/filings/0001558370-24-012050.md) | [7,154](/filings/0001558370-24-015516.md) | [7,138](/filings/0001558370-25-003018.md) | [7,163](/filings/0001558370-25-007164.md) | [7,205](/filings/0001558370-25-010918.md) | [7,194](/filings/0001104659-25-108453.md) | [7,230](/filings/0001104659-26-057877.md) | [7,293](/filings/0001104659-26-092675.md) | [7,280](/filings/0001104659-25-108453.md) | [7,234](/filings/0001104659-26-057877.md) | [7,220](/filings/0001104659-26-092675.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 7,055,424 at 2026-07-31, from the cover of the [10-Q filed 2026-08-07](/filings/0001104659-26-092675.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.